Racementhol

Racementhol

SCHEMBL521946

CC(C)[C@H]1CC[C@H](C)C[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of Racementhol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TRPM8 known ✓ Q7Z2W7 5/20 1.00
TRPA1 known ✓ O75762 2/20 1.00
EPHX1 P07099 3/20 0.52
ALDH1A1 P00352 1/20 0.41
KCNA5 P22460 1/20 0.39
TRPV1 Q8NER1 3/20 0.38
LMNA P02545 1/20 0.36
OPRM1 P35372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(+)-Menthol SCHEMBL10072505 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL15449169 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Isomenthol SCHEMBL677675 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL9968934 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL1709231 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+) Neomenthol SCHEMBL260049 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL12646785 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL13059620 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Menthol SCHEMBL20771511 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL2454317 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 715 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079744-A Method for resolution of D, L-menthol enantiomer 2026-05-26 CN claimed
CN-122060258-A Long-acting antibacterial mildew-proof resin material for edge banding and preparation method thereof 湖北登泰新材科技有限公司 2026-05-19 CN claimed
US-12630855-B2 Polypeptide having esterification activity for L-menthol and/or hydrolyzing activity for L-menthol ester AMANO ENZYME INC. (JP) 2026-05-19 US claimed
EP-3720563-B9 ORAL CARE COMPOSITIONS KENVUE BRANDS LLC (US) 2026-05-06 EP claimed
EP-3720563-B1 ORAL CARE COMPOSITIONS KENVUE BRANDS LLC (US) 2026-01-07 EP claimed
EP-4663203-A1 COMBINATION OF SGLT2 INHIBITOR AND MENTHOL AND USE THEREOF IN TREATMENT OF HEART DISEASE East China University of Science and Technology (CN) 2025-12-17 EP claimed
US-20250360091-A1 COMBINATION OF SGLT2 INHIBITOR AND MENTHOL AND USE THEREOF IN TREATMENT OF HEART DISEASE UNIV EAST CHINA SCIENCE & TECH (CN) 2025-11-27 US claimed
EP-3313372-B2 PACKAGED SILICONE LUBRICATED CONDOM THAT PROVIDES SENSATION LIFESTYLES HEALTHCARE PTE LTD (SG) 2025-11-26 EP claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
CN-109704943-B Method for preparing optically pure L-menthone and catalyst used in method 万华化学集团股份有限公司 2022-07-12 CN claimed
CN-113292532-B Polysubstituted naphthoquinone derivative and preparation method and application thereof 中山大学 2022-06-28 CN claimed
WO-2022122134-A1 COMPOSITIONS WITH (BIO)-ALKANEDIOLS AND COOLING AGENTS SYMRISE AG (DE) 2022-06-16 WO claimed
WO-2022122903-A1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS AND COOLING AGENTS SYMRISE AG (DE) 2022-06-16 WO claimed
CN-110841613-B Chiral separation multifunctional cellulose-based material and preparation method thereof 合肥工业大学 2022-05-17 CN claimed
CN-114487169-A Chiral amino acid detection method 宁波大学 2022-05-13 CN claimed
CN-112250556-B Preparation method of menthone 万华化学集团股份有限公司 2022-04-22 CN claimed
CN-111617646-B Preparation method of chiral conjugated microporous polymer/silicon dioxide composite membrane 齐齐哈尔大学 2022-03-04 CN claimed
US-20180280294-A1 THERAPEUTIC PUTTY HAVING ANALGESICS AND/OR COUNTERIRRITANTS GOLDBERG, ELLIOTT 2018-10-04 US claimed
EP-1218063-B1 PHARMACEUTICAL COMPOSITION CONTAINING TRICHLOROACETIC ACID, 2-OH BENZOIC ACID AND MENTHOL FOR TOPICAL APPLICATION AND PROCESS FOR THE PREPARATION THEREOF STRUMILLO MARIA (IT) 2004-04-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 TRPM8 205/4885TRPA1 71/4885EPHX1 3703/4885
US-12630855-B2 Polypeptide having esterification activity for L-menthol and/or hydrolyzing activity for L-menthol ester MLEC, METTL16, METTL14 TRPM8 326/4885TRPA1 2828/4885EPHX1 1607/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 TRPM8 171/4885TRPA1 4/4885EPHX1 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.